Agitation Archives - Page 4 of 5

Agitation Associated With Alzheimer’s Dementia Disease State Education: Clinical, Humanistic & Economic Burden

Live Event November 5 7:00 pm to 9:00 pm EST

Brijesh Patel, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka… Read More

The Agitation in Alzheimer’s Screener for Caregivers (AASC™) Scale Brochure

Downloadable Resource October 3, 2024

The Agitation in Alzheimer’s Screener for Caregivers (AASC™) is a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders and was designed… Read More

ICD-10-CM Diagnosis Code Quick Reference Guide

Infographic October 2, 2024

This list includes ICD-10 codes that may be relevant for patients with agitation associated with dementia due to Alzheimer’s disease. Read More

Addressing Caregiver Burden & Identifying Agitation in Alzheimer’s Dementia

Webinar November 13 12:00 pm to 1:00 pm EST

Come and join us for this webinar, as our speaker and moderator highlight the impact of caregiver burden, discuss challenges in recognizing agitation in Alzheimer’s dementia, and share tools that… Read More

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Live Event October 23 6:30 pm to 8:30 pm EDT

This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in… Read More

The Agitation in Alzheimer’s Screener For Caregivers (AASC™) – A New Tool To Disease Recognition

Live Event October 15 6:30 pm to 8:00 pm CDT

This presentation focuses on defining agitation in Alzheimer’s dementia including symptom presentation, prevalence and burden on patients and caregivers. Read More

Virtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems

Regional/Local November 12 12:00 pm to 1:00 pm EST

Becky Wong, PharmD, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) E. Jeffrey Greenberg, MD is a paid speaker on behalf of Otsuka Pharmaceutical Development &… Read More

Virtual Event – The Agitation in Alzheimer’s Screener For Caregivers (AASC™) – A New Tool To Disease Recognition

Regional/Local October 17 2:00 pm to 3:00 pm EDT

Michelle Lavagnino, DrPH(c) and Becky Wong, PharmD, MBA are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) Read More

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Live Event August 22 6:30 pm to 8:30 pm CDT

Amaka Onyereri, PharmD, BCPS (OPDC) is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization… Read More

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Live Event August 22 6:00 pm to 9:00 pm CDT

Linzy Hendrickson, PhD (OPDC) is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.,… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: